Lymphoscintigraphy and Gamma Probe–Guided Surgery in Papillary Thyroid Carcinoma
- 1 October 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 24 (10) , 744-6
- https://doi.org/10.1097/00003072-199910000-00002
Abstract
The authors report the use of lymphoscintigraphy and gamma probe–guided resection of the sentinel lymph node in a 65-year-old woman with clinically and cytologically indicated metastasizing papillary thyroid carcinoma. The results of the preoperative lymphoscintigraphy corresponded well with FDG PET and histologic findings, which gives promise of its validity in thyroid carcinoma. With experience in ultrasound-guided fine-needle aspiration biopsy, this method can be performed without any serious side effects for the patient. The validity of the sentinel lymph node concept in thyroid carcinoma and a possible improvement of nodal staging and local recurrence rate must still be proved.Keywords
This publication has 7 references indexed in Scilit:
- Sentinel Lymphadenectomy in Thyroid Malignant NeoplasmsArchives of Surgery, 1998
- Lymph node micrometastases from breast carcinomaCancer, 1997
- Gamma Probe-Guided Resection of a Lymph Node Metastasis With I-123 in Papillary Thyroid CarcinomaClinical Nuclear Medicine, 1997
- Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodesThe Lancet, 1997
- Lymphoscintigraphy, the sentinel node concept, and the intraoperative gamma probe in melanoma, breast cancer, and other potential cancersSeminars in Nuclear Medicine, 1997
- Minimal-Access Surgery for Staging of Malignant MelanomaArchives of Surgery, 1995
- Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancerThe American Journal of Medicine, 1994